Nervous system of Pediculus humanus capitis

The neurological machinery of Pediculus humanus capitis (the head louse) refers to the collective physiological components, including ion channels and enzymes, that govern the parasite's nervous system functions (Yoon et al., 2014, PubMed: 24571194). This system is the primary target for most chemical pediculicides used to treat head lice infestations, known as pediculosis capitis (Clark, 2009, PubMed: 19475301). Key molecular targets within this machinery include voltage-gated sodium channels, which are modulated by pyrethroids like permethrin to cause paralysis, and acetylcholinesterase, which is inhibited by organophosphates like malathion (Strycharz et al., 2008, PubMed: 18947055). Other targets include nicotinic acetylcholine receptors (nAChR) and glutamate-gated chloride channels (GluCl), which are affected by spinosad and ivermectin, respectively (Kirst, 2010, PubMed: 20143935). The development of resistance, particularly through knockdown resistance (kdr) mutations in the sodium channel gene, represents a significant therapeutic challenge in managing infestations (Yoon et al., 2008, PubMed: 18465184). Understanding these neurological targets is essential for developing new treatments that maintain high insecticidal efficacy while ensuring low toxicity to the human host.

Other names

Neurological machinery of Pediculus humanus capitisHead louse nervous systemPediculicide targets

Pediculicides target the nervous system through various mechanisms: pyrethroids and pyrethrins delay the closing of voltage-gated sodium channels, leading to repetitive firing and paralysis; malathion irreversibly inhibits acetylcholinesterase, causing acetylcholine accumulation and overstimulation; spinosad activates nicotinic acetylcholine receptors; and ivermectin binds to glutamate-gated chloride channels, increasing membrane permeability to chloride ions and causing flaccid paralysis (Yoon et al., 2014, PubMed: 24571194; Clark, 2009, PubMed: 19475301).